Lifitegrast sodium T3977L
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Lifitegrast sodium (SAR-1118) is an LFA-1 antagonist for the therapy of vascular complications of the eye. It inhibits T cell-mediated inflammation by blocking the binding of two cell surface proteins (lymphocyte function-associated antigen 1 and intercel
CAS nr:
1119276-80-0
Purity:
98%
Molecular Weight:
637,45
SMILES:
CS(=O)(c1cc(C[C@H](NC(c2c(Cl)c(CCN(C(c(cc3)cc4c3cco4)=O)C5)c5cc2Cl)=O)C([O-])=O)ccc1)=O.[Na+]
Formula:
C29H23Cl2N2NaO7S
Pathway:
Target:
